Sen. Chuck Grassley (R-Iowa) calls for the Obama Administration to put the final touches on the Physician Payments Sunshine Act, a bill that Grassley co-authored and introduced in 2007.
MASSDEVICE ON CALL — Senator Chuck Grassley (R-Iowa) this week sent an open letter to the Obama Administration, expressing "disappointment" that health regulators have yet to issue final rules on the Sunshine Act, delaying efforts to make relationships between healthcare providers and the healthcare industry more transparent.
"It will be 3 years in March since the Sunshine Act was enacted," Grassley said. "Three years is a long time for pretty straightforward regulations."
Grassley helped co-author the Physician Payments Sunshine Act and introduced it Congress in 2009 with co-sponsor Herb Kohl (D-Wisc).
The Centers for Medicare & Medicaid are now 15 months overdue on issuing final rules, possibly pushing data collection and the publication of the financial relationships between doctors and medical device and drug manufacturers back another year, Grassley noted.
"While many interactions between medical professionals and the pharmaceutical and medical device industry are vital to the advancement of medical science and patient care, the Sunshine Act was developed after numerous investigations and hearings revealed that large sums of money were going to physicians for questionable purposes," Grassley wrote in a letter to White House Chief of Staff Jacob Lew. "These delays are disrupting the considerable efforts of the pharmaceutical and medical device manufacturers that are already investing in systems to comply with the law, as well as voluntary efforts of universities and even the National Institutes of Health to promote more transparent relationships between physicians and industry."
Saphena Medical, which is developing a device to harvest veins for coronary artery bypass grafting,...
The shareholders of both Uroplasty and Vision-Sciences approve their pending million merger.
InVivo Therapeutics adds the 4th site to a feasibility study of its biodegradable implant to treat...
The Centers for Disease Control & Prevention are hoping a program piloted in Chicago will help...
Regulators in Japan approve Medtronic's CoreValve transcatheter aortic valve implant.